Fundamental analysis · SEC EDGAR · TTM through 27/06/2026
HSIC · Nasdaq · Healthcare
Fundamental quality
50
out of 100
Henry Schein Inc earns a fundamental-quality score of 50 out of 100, profiling it as a company with demanding fundamentals. Its score rests mainly on its profitability (net margin 3%). Its weakest area is its growth (revenue +5.5%/yr). Whether it's cheap or expensive depends on the current price, which you can compute in the tool.
Henry Schein is the world's largest dental-supplies distributor: the provider stocking dentists' offices with gloves, implants, equipment and practice software, plus a medical arm for outpatient practices. Dentistry's indispensable middleman.
EPS growth: 3.6% · Revenue growth: 5.5%
Net margin: 3% · ROE: 12.8% · ROIC: 8.2%
Net debt/EBITDA: 3.14x · FCF: 4.2%
Source: SEC EDGAR · TTM through 27/06/2026
The score combines growth, profitability and financial strength. Here its profitability weighs in its favor, while its growth drags it down the most.
Percentile against the other 57 Healthcare companies in our coverage: how far it beats them on each metric (100 = best in sector).
Computed from the daily dataset scores. A high percentile places the company among the best in its sector on that metric; it is not a buy recommendation.
Key concepts
What do these metrics mean? Fundamental analysis · What is the P/E · What is EPS · What is ROE · Net & gross margin · Free cash flow
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2020 | 10,119 | 404 | 550 | 168 |
| 2021 | 12,401 | 631 | 631 | 755 |
| 2022 | 12,647 | 538 | 506 | 1,032 |
| 2023 | 12,339 | 416 | 353 | 2,030 |
| 2024 | 12,673 | 390 | 700 | 2,358 |
| 2025 | 13,184 | 398 | 573 | 2,918 |
Between 2020 and 2025, revenue went from $10,119M to $13,184M (+30%) and net income went from $404M to $398M (-1%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Latest results
Figures for the half-year ended June 27, 2026, versus the half-year ended June 28, 2025 (SEC filings):
Compared with the previous close (March 28, 2026), this is what moved in its accounts:
Automatic comparison between the two most recent periods filed with the SEC. One quarter doesn't make a trend: read it alongside the historical evolution above.
This company doesn't pay a dividend: it reinvests all its earnings back into the business.
Open your account in minutes with regulated brokers and buy U.S. and European stocks from small amounts. No paperwork.
The serious investor's standard
Open free account →Anyone who wants low commissions and access to almost any market in the world.
Popular in the U.S.
Open free account →Anyone investing in the U.S. who wants a powerful, commission-free stock app.
Investing carries risk of loss.
Is Henry Schein Inc cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Is Henry Schein Inc a good company to invest in?
In terms of business quality, Henry Schein Inc scores 50 out of 100 in our analysis, placing it as a company with demanding fundamentals. That said, this isn't a recommendation: whether it's a good investment also depends on its current price and your goals.
Is Henry Schein Inc a profitable company?
Henry Schein Inc is profitable, with a net margin of 3%, though a thin one.
Does Henry Schein Inc have a lot of debt?
Yes, its leverage is high: net debt is 3.14 times its EBITDA, and it has been rising.
Is Henry Schein Inc growing?
Its revenue has grown 5.5% annualized in recent years and its earnings per share 3.6%.
Does Henry Schein Inc generate cash?
Yes. It converts about 4.2% of its revenue into free cash flow, and has done so positively year after year.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
More Healthcare companies
McKesson (MCK) · Zoetis (ZTS) · CVS Health (CVS) · 3M (MMM) · HCA Healthcare (HCA) · Becton Dickinson (BDX) · see more →
The best Healthcare stocks by our model →
Compare Henry Schein Inc with 500+ companies in the screener →
Who's behind the methodology and model · how the score is computed
Data: see Henry Schein Inc's filings on EDGAR
Spotted a figure that looks wrong? Report it and we'll review it.